Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
Go back to Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
September 14, 2024 3:00 AM EDT
- 4.3 mg/kg of luveltamab tazevibulin (luvelta) in combination with standard dose of bevacizumab (15Â mg/kg) every 3 weeks resulted in a 56% objective response rate in patients with late-stage ovarian cancer and was selected to be the recommended phase 2 dose (RP2D) -
- Luvelta in combination with bevacizumab demonstrated encouraging preliminary antitumor activity (35% response rate) across all explored dose ranges -
- Expansion at RP2D is ongoing with an additional 23 patients enrolled to date; expansion data are expected in the first half of 2025 -
- No... More
September 13, 2024 3:00 AM EDT
OSLO, Norway--(BUSINESS WIRE)--
StrongPoint, a retail technology firm focused on making stores and supply chains smarter, have successfully installed the world's first AutoStore Multi-Temperature Solution with a frozen zone. The inaugural site has been installed for Haugaland Storhusholdning, part the Norwegian food distribution group DLVRY, in a facility based in Sveio, Norway.
This press release features multimedia. View the full... More
